CN1640446A - Medicine for treating cancer - Google Patents

Medicine for treating cancer Download PDF

Info

Publication number
CN1640446A
CN1640446A CN 200410010022 CN200410010022A CN1640446A CN 1640446 A CN1640446 A CN 1640446A CN 200410010022 CN200410010022 CN 200410010022 CN 200410010022 A CN200410010022 A CN 200410010022A CN 1640446 A CN1640446 A CN 1640446A
Authority
CN
China
Prior art keywords
grams
medicine
gram
carcinoma
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 200410010022
Other languages
Chinese (zh)
Inventor
李加飞
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 200410010022 priority Critical patent/CN1640446A/en
Publication of CN1640446A publication Critical patent/CN1640446A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention discloses a medicine for curing cancers. It is characterized by that it is an injection preparation prepared by extracting effective components of the Chinese medicinal materials of rabdosia rubescens, gentian root, rhinoceros horn, black nightshade, bushy sophora root, epimedium and walnut twigs. Said invented medicine mainly can be used for curing carcinoma of esophagus, carcinoma of stomach, hepatis carcinoma, oral carcinoma and cervical carcinoma, and its effective rate can be up to above 95%.

Description

The medicine of treatment cancer
Technical field
The present invention relates to a kind of Chinese medicine, especially relate to a kind of medicine for the treatment of cancer.
Background technology
Cancer is human pertinacious disease, and patient is agonizing, cancer of late stage especially, and pain is unbearably.At present, the medicine of treatment cancer commonly used is a lot of both at home and abroad, also all has certain effect.But also all there is certain weak point.Such as, though chemotherapy has certain effect, side effect is big.Generally all with vomiting, feel sick, heating, headache, untoward reaction such as weak.In addition, also can cause leukocyte and platelet counts to descend.And can produce acute painful.Patient is difficult to stand.
Summary of the invention
Purpose of the present invention just is to provide a kind of therapeutic effect well also can avoid the medicine of the treatment cancer of many side effect.
Purpose of the present invention can realize by following measure:
The present invention includes following extract drugs injection, comprise Rabdosia rubescens 10~80 grams, Radix Gentianae 5~50 grams, native Cornu rhinocerotis 0.5~30 gram, Herba Solani Nigri 0.5~50 gram, root of subprostrate sophora 15~50 grams, Herba Epimedii 5~50 grams, Ramulus Juglandis 0.5~50 gram.
Also comprise Herba Scutellariae Barbatae 10~20 grams in the medicine of the extraction injection among the present invention, Herba Lobeliae Chinensis 15~25 grams are spent tongue SHECAO 15~30 grams in vain.
The present invention has effects such as pain relieving, antiinflammatory owing to adopt above-mentioned prescription.For many years through multiple treatment for cancer is observed, it is as follows totally to treat data: to the esophageal carcinoma: treatment number 145 examples, effectively number 117 examples; Gastric cancer: treatment number 57 examples, effectively number 36; Hepatocarcinoma: treatment number 13 examples, effectively number 8; Oral cancer: treatment number 6 examples, effectively number 4; Cervical cancer: 4 examples, effective 3.Total effective rate reaches more than 80%.For the eliminate pain aspect, effective percentage reaches more than 95%.With respect to dolantin, though but the dolantin pain relieving is habit-forming easily, and this medicine can be addicted.With respect to chemotherapy, the present invention uses and does not find obvious toxic and side effects for many years.
The specific embodiment
The present invention does with detailed description below in conjunction with embodiment:
Embodiment 1: the present invention includes the injection of following extract drugs, comprise Rabdosia rubescens 10~80 grams, Radix Gentianae 5~50 grams, soil Cornu rhinocerotis 0.5~30 gram, Herba Solani Nigri 0.5~50 gram, root of subprostrate sophora 15~50 grams, Herba Epimedii 5~50 grams, Ramulus Juglandis 0.5~50 gram, Herba Scutellariae Barbatae 10~20 grams.The process of said extracted injection is the common process method.
Treatment mechanism of the present invention is as follows: the traditional Chinese medical science thinks that cancer is under the effect of paathogenic factor, has destroyed the relative equilibrium of human body, is not just pressing heresy, cause a disease and send out.The formation of tumor is the pathological product that forms in the pathogenesis process by qi depression to blood stasis, is again the paathogenic factor of some inflammation disease.The present invention is according to theory of Chinese medical science, QI and blood regulating, and blood circulation promoting and blood stasis dispelling, dispersing swelling and dissipating binds is removed the patient and is had an intense pain.
Embodiment 2: the present invention includes the injection that following component is extracted, comprise Rabdosia rubescens 10~80 grams, Radix Gentianae 5~50 grams, soil Cornu rhinocerotis 0.5~30 gram, Herba Solani Nigri 0.5~50 gram, root of subprostrate sophora 15~50 grams, Herba Epimedii 5~50 grams, Ramulus Juglandis 0.5~50 gram, Herba Lobeliae Chinensis 15~25 grams.Treatment mechanism is with embodiment 1.
Embodiment 3: the present invention includes the injection that following component is extracted, comprise Rabdosia rubescens 10~80 grams, Radix Gentianae 5~50 grams, native Cornu rhinocerotis 0.5~30 gram, Herba Solani Nigri 0.5~50 gram, root of subprostrate sophora 15~50 grams, Herba Epimedii 5~50 grams, Ramulus Juglandis 0.5~50 gram, Herba Scutellariae Barbatae 10~20 grams, Herba Lobeliae Chinensis 15~25 grams are spent tongue SHECAO 15~30 grams in vain.Treatment mechanism is with embodiment 1.

Claims (4)

1, a kind of medicine for the treatment of cancer, it is characterized in that: it comprises the injection of following extract drugs, comprises Rabdosia rubescens 10~80 grams, Radix Gentianae 5~50 grams, native Cornu rhinocerotis 0.5~30 gram, Herba Solani Nigri 0.5~50 gram, root of subprostrate sophora 15~50 grams, Herba Epimedii 5~50 grams, Ramulus Juglandis 0.5~50 gram.
2, the medicine of treatment cancer according to claim 1 is characterized in that: also comprise Herba Scutellariae Barbatae 10~20 grams in the medicine of described extraction injection.
3, the medicine of treatment cancer according to claim 1 is characterized in that: also comprise Herba Lobeliae Chinensis 15~25 grams in the medicine of described extraction injection.
4, according to the medicine of claim 1 or 2 or 3 described treatment cancers, it is characterized in that: also comprise in the medicine of described extraction injection and spend tongue SHECAO 15~30 grams in vain.
CN 200410010022 2004-01-12 2004-01-12 Medicine for treating cancer Pending CN1640446A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 200410010022 CN1640446A (en) 2004-01-12 2004-01-12 Medicine for treating cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 200410010022 CN1640446A (en) 2004-01-12 2004-01-12 Medicine for treating cancer

Publications (1)

Publication Number Publication Date
CN1640446A true CN1640446A (en) 2005-07-20

Family

ID=34867685

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 200410010022 Pending CN1640446A (en) 2004-01-12 2004-01-12 Medicine for treating cancer

Country Status (1)

Country Link
CN (1) CN1640446A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105012789A (en) * 2015-08-13 2015-11-04 李荣勤 Composition for treating cervical cancer and preparation method thereof
CN105168930A (en) * 2015-09-28 2015-12-23 张光荣 Chinese herb preparation for preventing and treating cerebral cancer
CN105168656A (en) * 2015-09-28 2015-12-23 张光荣 Preparation with anti-cancer effect and preparation method
CN105168781A (en) * 2015-09-28 2015-12-23 张光荣 Traditional Chinese medicine composite for treating brain cancer and preparation method thereof
CN106038765A (en) * 2016-08-12 2016-10-26 郑州大学 Application of compound Rabdosia rubescens preparation to chemical prevention of esophagus cancer

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105012789A (en) * 2015-08-13 2015-11-04 李荣勤 Composition for treating cervical cancer and preparation method thereof
CN105168930A (en) * 2015-09-28 2015-12-23 张光荣 Chinese herb preparation for preventing and treating cerebral cancer
CN105168656A (en) * 2015-09-28 2015-12-23 张光荣 Preparation with anti-cancer effect and preparation method
CN105168781A (en) * 2015-09-28 2015-12-23 张光荣 Traditional Chinese medicine composite for treating brain cancer and preparation method thereof
CN106038765A (en) * 2016-08-12 2016-10-26 郑州大学 Application of compound Rabdosia rubescens preparation to chemical prevention of esophagus cancer

Similar Documents

Publication Publication Date Title
CN101062175A (en) Decoction made from catnip, fang-feng and so on
CN101129573A (en) Traditional Chinese medicine for treating acute bronchitis
CN1640446A (en) Medicine for treating cancer
CN103990002A (en) Traditional Chinese medicinal composition for treating liver cancer
CN101612347A (en) A kind of healthy medicated wine for the treatment of menoxenia
CN101062259A (en) Lily bolus for clearing lung heat
CN102824445A (en) Traditional Chinese medicine composition for treating duodenal ulcer
CN103100048B (en) Chinese herbal preparation for treating pharyngolaryngeal cancer and preparation method thereof
CN102028831B (en) Traditional Chinese medicine composition for treating tumors or cancers and preparation method thereof
CN102441131A (en) Chinese medicinal composition for treating traumatic injury
CN101062280A (en) Decoction made from radix adenophorea, tuber of dwarf lilyturf and so on
CN101612236A (en) A kind of medicated wine for the treatment of anemopyretic cold
CN111084878A (en) Biological medicine and medical total nutrient food for lung and respiratory system diseases and preparation method thereof
CN1085439A (en) A kind of anticancer herbal drug
CN101396454B (en) Traditional Chinese medicine for treating diabetic skin pruritus
CN102058860A (en) Traditional Chinese medicine for treating pig chronic superficial gastritis
CN1058878C (en) Medicine for treatment of multiple middle-advanced stage cancer
CN1132609C (en) Oral liquid for removing endogenous heat
CN104971237A (en) Traditional Chinese medicine combined preparation for treating radiation esophagitis
CN1408393A (en) External-use traditional Chinese medicine for curing chronic rhinitis, nasosinusitis and laryngopharyngitis
CN1463731A (en) Medicament for treating pulmonary neoplasm, asthma and trachitis and method for making same
CN101181407B (en) Oral cavity medicine for curing chronic pharyngitis
CN101468197B (en) Medicament for treating tumor
CN1291742C (en) Chinese herbal medicine for stomach carcinoma
CN101804098B (en) Compound cornu cervi degelatinatum preparation as well as preparation method and application thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication